Liver Transplantation for Acute‐on‐Chronic Liver Failure: Science or Fiction?
Jonel Trebicka, Vinay Sundaram, Richard Moreau, Rajiv Jalan, Vicente Arroyo – 4 May 2020 – Acute clinical deterioration of a patient with chronic liver disease remains a decisive time point both in terms of medical management and prognosis. This condition, also known as acute decompensation (AD), is an important event determining a crossroad in the trajectory of patients.
Risk Factors and Center‐Level Variation in Hepatocellular Carcinoma Under‐Staging for Liver Transplantation
Nadim Mahmud, Maarouf A. Hoteit, David S. Goldberg – 4 May 2020 – Liver transplantation (LT) is curative for most patients with hepatocellular carcinoma (HCC). However, 10%‐15% of patients experience HCC recurrence. Patients who are reported as within Milan criteria by imaging are frequently found to be outside the criteria on explant. This under‐staging of HCC worsens post‐LT outcomes. However, risk factors for under‐staging have not been elucidated. Furthermore, it is not known if there is regional or center‐level variation in under‐staging.
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
Fang Lei, Ye‐Mao Liu, Feng Zhou, Juan‐Juan Qin, Peng Zhang, Lihua Zhu, Xiao‐Jing Zhang, Jingjing Cai, Lijin Lin, Shan Ouyang, Xiaoming Wang, Chengzhang Yang, Xu Cheng, Weifang Liu, Haomiao Li, Jing Xie, Bin Wu, Huiming Luo, Fei Xiao, Jing Chen, Liang Tao, Gang Cheng, Zhi‐Gang She, Jianghua Zhou, Haitao Wang, Jun Lin, Pengcheng Luo, Shouzhi Fu, Jihui Zhou, Ping Ye, Bing Xiao, Weiming Mao, Liming Liu, Youqin Yan, Ling Liu, Guohua Chen, Hongliang Li, Xiaodong Huang, Bing‐Hong Zhang, Yufeng Yuan – 2 May 2020
Establishment of a Patient‐Derived Xenograft Tumor From Hepatitis C–Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy
Mustafa Nazzal, Subhayan Sur, Robert Steele, Mousumi Khatun, Tapas Patra, Nancy Phillips, John Long, Ranjit Ray, Ratna B. Ray – 1 May 2020
Issue Information
30 April 2020
Resection of Mixed Hepatocellular‐Cholangiocarcinoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
Matthew L. Holzner, Parissa Tabrizian, Fatemeh P. Parvin‐Nejad, Kezhen Fei, Ganesh Gunasekaran, Chiara Rocha, Marcelo E. Facciuto, Sander Florman, Myron E. Schwartz – 30 April 2020 – Mixed hepatocellular‐cholangiocarcinoma (HCC‐CC) is a biphenotypic liver cancer thought to have unfavorable tumor biology and a poor prognosis. Surgical outcomes of HCC‐CC remain unclear. We aimed to evaluate the clinical characteristics and surgical outcomes of HCC‐CC.
Hepatology Highlights
Joseph F. Pisa, Robert S. Brown, Petra Hirsova, Robert E. Schwartz, Tejasav S. Sehrawat, Nicholas W. Russo, Enis Kostallari, Zaid H. Tafesh, Brett Fortune, Hirsh D. Trivedi, Daryl T.Y. Lau, Angel Morales‐Santiago, Joel Wedd, Samuel C. Buchl, Jessica L. Maiers – 29 April 2020
Could Autoimmune Disease Contribute to the Abscopal Effect in Metastatic Hepatocellular Carcinoma?
Carolien Beyls, Karin Haustermans, Christophe M. Deroose, Steven Pans, Dirk Vanbeckevoort, Chris Verslype, Jeroen Dekervel – 29 April 2020
Correction
29 April 2020